HomeCYTO • CVE
add
Cytophage Technologies Ltd
Previous close
$0.17
Day range
$0.17 - $0.17
Year range
$0.13 - $0.40
Market cap
11.51M CAD
Avg Volume
22.80K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.02M | -7.78% |
Net income | -1.04M | 4.96% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -994.52K | -7.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 354.68K | -85.00% |
Total assets | 3.18M | -48.18% |
Total liabilities | 2.01M | 2.52% |
Total equity | 1.17M | — |
Shares outstanding | 67.69M | — |
Price to book | 8.50 | — |
Return on assets | -69.77% | — |
Return on capital | -83.10% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.04M | 4.96% |
Cash from operations | -800.20K | 7.63% |
Cash from investing | -9.24K | 97.46% |
Cash from financing | -74.62K | 0.00% |
Net change in cash | -884.06K | 32.23% |
Free cash flow | -445.44K | 51.33% |
